1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CARISMA THERAPEUTICS INC
Carisma Therapeutics Inc XNAS: CARM

Carisma Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...

Read More
0.34 0.00 (0.00%)
73.23% Fall from 52W High
227.6K
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Carisma Therapeutics Inc is on 08 Aug 2025 for the purpose of CARISMA Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
15.2 / 100
Momentum Score
Technically Bearish
29.1 / 100
Analyst Price Target
1
1Yr Price target upside is 194%
1 analysts

9

S

7

W

0

O

2

T

SWOT Analysis

Carisma Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..